Simultaneous editing of TCR, HLA-I/II and HLA-E resulted in enhanced universal CAR-T resistance to allo-rejection
Wuling Li(Chongqing University), Cheng Qian(Chongqing University), Xiuxiu Zhu(Chongqing University), Yunyan Li(Kunming Institute of Precious Metals), Zhi Yang, Hongtao Zhang(Chinese Academy of Sciences), Jun Chen, Guixue Wang(Chongqing University), Yanmin Xu, Juan Hong(Jiangsu University), Yanan Qi, Junjie Shen
Cited by 42
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435